Iratumumab

Iratumumab Uses, Dosage, Side Effects, Food Interaction and all others data.

Immunoglobulin G1, anti-(human CD30 (antigen)) (human monoclonal MDX-060 heavy chain), disulfide with human monoclonal MDX-060 light chain, dimer. Molecular weight is approximately 170,000 daltons. In phase I/II clinical trials for treatment of CD30+ lymphomas.

Trade Name Iratumumab
Generic Iratumumab
Iratumumab Other Names Iratumumab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Iratumumab
Iratumumab

Uses

Investigated for use/treatment in lymphoma (unspecified).

Innovators Monograph

You find simplified version here Iratumumab

*** Taking medicines without doctor's advice can cause long-term problems.
Share